SmallCap
CompaniesStatistics

에이비온(주)

Venture Certified
Data Quality: 9/10

Basic Information


Unlisted

Company Name에이비온(주)
English NameABION Inc.
Business Reg. No.2148807712
CEO신영기
Address서울특별시 구로구 디지털로 242 한화비즈메트로1차 242915호
Industry의학 및 약학 연구개발업
Industry Code70113
Main Products신약개발
EstablishedContact
Phone02-6006-7650
Websitewww.abionbio.com
Regular Employees102persons
Corp. Reg. No.1101113660142

Investment Metrics


Market Cap
-
Op. Margin
-999.99%
ROE
-154.22%
Debt Ratio
126.74%

Certification Status


Venture Certified

Cert. History
연구개발유형2009-12-10 ~ 2011-12-09200901109952009-12-10
연구개발유형2011-12-10 ~ 2013-12-09201101093472009-12-10
연구개발유형2013-12-10 ~ 2015-12-09201301132402009-12-10
연구개발유형2015-12-10 ~ 2017-12-09201501141702009-12-10
연구개발유형2017-12-10 ~ 2019-12-09201701149642009-12-10
기술평가보증기업(기금)2019-12-10 ~ 2021-12-09201901143822009-12-10
연구개발유형2021-12-10 ~ 2024-12-09202112080200572009-12-10
연구개발유형2024-12-10 ~ 2027-12-09202501140200122009-12-10

Financial Statements


4-Year Financial Data

Revenue CAGR -22.6%

Item2024202320222021
Revenue

7.6B

12.7B

25.1B

16.4B

Operating Profit

-340.7B

-312.5B

-251.7B

-106.7B

Net Profit

-433.8B

-292.1B

-199.3B

-542.6B

Total Assets

637.8B

446.7B

241.4B

446.2B

Total Liabilities

356.5B

346.9B

90.4B

125.2B

Total Equity

281.3B

99.8B

151.0B

321.0B

Risk Indicators


3 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
8B

57.9%

vs. 3-Year Avg.: 18B
Operating Profit
-341B

52.3%

vs. 3-Year Avg.: -224B
Op. Margin
-4484.2%

227.5%

vs. 3-Year Avg.: -1369.3%
Debt Ratio
126.7%

14.9%

vs. 3-Year Avg.: 148.8%
ROE
-154.2%

22.1%

vs. 3-Year Avg.: -197.9%

Officers / Major Shareholders


NamePositionRoleComp. (M KRW)
신영기사내이사CEO/CTO (최고경영자, 기술총괄)-
강진우미등기기획-
윤성노미등기재무-
김윤범미등기법무-
이영휘미등기기획실장-
장선미미등기개발본부장-
백운선미등기임상-
김종란미등기연구개발부문장-
최준영사내이사COO (최고운영책임자)-
우성윤사내이사CFO/CSO (재무/전략총괄)-
정윤택사외이사경영 자문-
양진욱사외이사경영 자문-
박근칠사외이사기술 자문-
주윤회감사경영 자문-
김나영미등기신사업개발-
박경의미등기개발-
ShareholderOwnership (%)Shares Held
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Employment Status


Regular Employees

102persons

CEO신영기

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "서울특별시 구로구",
  "ceo_name": "신영기",
  "certificate": [
    {
      "cert_number": "20090110995",
      "changes": "",
      "disclosure_date": "2009-12-10",
      "first_cert_date": "2009-12-10",
      "no": "1",
      "type": "연구개발유형",
      "valid_period": "2009-12-10 ~ 2011-12-09"
    },
    {
      "cert_number": "20110109347",
      "changes": "",
      "disclosure_date": "2011-12-30",
      "first_cert_date": "2009-12-10",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2011-12-10 ~ 2013-12-09"
    },
    {
      "cert_number": "20130113240",
      "changes": "",
      "disclosure_date": "2013-12-17",
      "first_cert_date": "2009-12-10",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2013-12-10 ~ 2015-12-09"
    },
    {
      "cert_number": "20150114170",
      "changes": "",
      "disclosure_date": "2015-12-21",
      "first_cert_date": "2009-12-10",
      "no": "4",
      "type": "연구개발유형",
      "valid_period": "2015-12-10 ~ 2017-12-09"
    },
    {
      "cert_number": "20170114964",
      "changes": "",
      "disclosure_date": "2017-12-21",
      "first_cert_date": "2009-12-10",
      "no": "5",
      "type": "연구개발유형",
      "valid_period": "2017-12-10 ~ 2019-12-09"
    },
    {
      "cert_number": "20190114382",
      "changes": "",
      "disclosure_date": "2019-12-06",
      "first_cert_date": "2009-12-10",
      "no": "6",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2019-12-10 ~ 2021-12-09"
    },
    {
      "cert_number": "20211208020057",
      "changes": "",
      "disclosure_date": "2021-12-08",
      "first_cert_date": "2009-12-10",
      "no": "7",
      "type": "연구개발유형",
      "valid_period": "2021-12-10 ~ 2024-12-09"
    },
    {
      "cert_number": "20250114020012",
      "changes": "",
      "disclosure_date": "2025-01-14",
      "first_cert_date": "2009-12-10",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2024-12-10 ~ 2027-12-09"
    }
  ],
  "company_name": "에이비온 주식회사",
  "corp_no": "110111-*******",
  "financials": {
    "2022": {
      "capital_stock": 9422618000,
      "cost_of_sales": 1786558000,
      "current_assets": 16826504000,
      "current_liabilities": 7551925000,
      "gross_profit": 719961000,
      "net_income": -19925391000,
      "net_income_bs": -19925391000,
      "non_current_assets": 7177671000,
      "non_current_liabilities": 1351979000,
      "non_operating_expenses": 1864812000,
      "non_operating_income": 6539507000,
      "operating_profit": -24600086000,
      "revenue": 2506519000,
      "sga_expenses": 25320047000,
      "total_assets": 24004175000,
      "total_equity": 15100271000,
      "total_liabilities": 8903904000
    },
    "2023": {
      "capital_stock": 11012996000,
      "cost_of_sales": 1258465000,
      "current_assets": 11985718000,
      "current_liabilities": 28049114000,
      "gross_profit": 15842000,
      "net_income": -29210914000,
      "net_income_bs": -29210914000,
      "non_current_assets": 32611195000,
      "non_current_liabilities": 6568376000,
      "non_operating_expenses": 5603519000,
      "non_operating_income": 7089629000,
      "operating_profit": -30697024000,
      "revenue": 1274307000,
      "sga_expenses": 30712866000,
      "total_assets": 44596913000,
      "total_equity": 9979423000,
      "total_liabilities": 34617490000
    },
    "2024": {
      "capital_stock": 14318708000,
      "cost_of_sales": 537179000,
      "current_assets": 3499157000,
      "current_liabilities": 32071995000,
      "gross_profit": 222505000,
      "net_income": -43187725000,
      "net_income_bs": -43187725000,
      "non_current_assets": 59454526000,
      "non_current_liabilities": 2557676000,
      "non_operating_expenses": 18298054000,
      "non_operating_income": 8422558000,
      "operating_profit": -33312229000,
      "revenue": 759684000,
      "sga_expenses": 33534734000,
      "total_assets": 62953683000,
      "total_equity": 28324012000,
      "total_liabilities": 34629671000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [],
  "main_products": "신약개발",
  "phone": "010-6813-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 9/10 | Primary Source: Venture System | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsDART
Collected
Investment MetricsDART
Collected
OfficersDART
Collected
EmploymentDART
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
DART Financial2026-02-28
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected
Venture System Detail2026-02-25
Collected